Citi downgraded GE HealthCare (GEHC) to Neutral from Buy with a price target of $83, down from $93, ahead of the Q3 report. The firm sees the stock trading sideways given a lack of confidence in the company’s mid-single-digit revenue growth outlook for 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Lantheus rallies after inking GE licensing agreement for Japan
- Nvidia to invest $5B in Intel, ABC pulls ‘Jimmy Kimmel Live!’: Morning Buzz
- GE Healthcare’s Strategic Consideration: Evaluating the Potential Exit from China Amid Challenging Market Conditions
- Morgan Stanley says GE Healthcare considering exiting China not surprising
- GE HealthCare weighing China business stake sale, Bloomberg reports